Hindi nagbibigay ng serbisyo ang XM sa mga residente ng Estados Unidos.

Hindi nagbibigay ng serbisyo ang XM sa mga residente ng Estados Unidos.
A
A

Agilent

Balita

Reuters - 2 linggo ang nakaraan

Waters Corp climbs after Q2 results beat

BUZZ-Waters Corp climbs after Q2 results beat Updates ** Shares of lab equipment maker Waters Corp WAT.N rise ~4.1% to $341.09, their highest since May ** WAT reports Q2 adj. profit of $2.63/shr vs analysts' average estimate of $2.56/shr - LSEG data ** Posts quarterly revenue of $708.5 mln vs analysts' expectation of $700.1 mln ** Company forecasts annual adj.
A
W
Reuters - 2 linggo ang nakaraan

Waters Corp falls on annual profit forecast cut

BUZZ-Waters Corp falls on annual profit forecast cut ** Shares of lab equipment maker Waters Corp WAT.N fall ~2.3% to $320.01 premarket ** Co forecasts annual adj. profit between $11.55 and $11.65 per share below previous forecast of $11.75-$12.05 ** Evercore analyst Vijay Kumar says WAT's forecast cut was "generally expected" given peer Agilent's A.N revenue forecast cut in May ** WAT reports Q2 adj.
A
W
Reuters - 3 linggo ang nakaraan

Deals of the day-Mergers and acquisitions

Deals of the day-Mergers and acquisitions Adds: Mattel, Tellurian Updates: Clearwater Paper, Agilent July 22 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1955 GMT on Monday: * * L Catterton, the private equity firm backed by luxury goods giant LVMH LVMH.PA , has approached Mattel MAT.O , the toy maker behind Barbie and Hot Wheels, with an acquisition offer, people familiar with the matter said.
A
G
H
L
M
V
D
Reuters - 3 linggo ang nakaraan

Agilent Technologies To Acquire BIOVECTRA for $925 Million

BRIEF-Agilent Technologies To Acquire BIOVECTRA for $925 Million July 22 (Reuters) - Agilent Technologies Inc A.N : AGILENT TO ACQUIRE NORTH AMERICAN CDMO BIOVECTRA AGILENT TECHNOLOGIES INC - TO ACQUIRE BIOVECTRA FOR $925 MILLION AGILENT TECHNOLOGIES INC - EXPECTS ACQUISITION TO BE $0.05 DILUTIVE TO NON-GAAP EPS Source text for Eikon: ID:nBw5TcW1Fa
A
Reuters - 3 linggo ang nakaraan

Agilent to buy contract drug manufacturer Biovectra for $925 mln

UPDATE 2-Agilent to buy contract drug manufacturer Biovectra for $925 mln Adds deal details in paragraph 5 and background throughout July 22 (Reuters) - Agilent Technologies A.N said on Monday it will acquire contract drug manufacturer Biovectra for $925 million to expand its portfolio of services offered to biotech companies and medical researchers.
A
Reuters - 3 linggo ang nakaraan

Agilent to buy contract drug manufacturer Biovectra for $925 million

Agilent to buy contract drug manufacturer Biovectra for $925 million July 22 (Reuters) - Medical equipment maker Agilent Technologies A.N said on Monday it will acquire privately held contract drug manufacturer Biovectra for $925 million. Reporting by Mariam Sunny in Bengaluru; Editing by Shounak Dasgupta
A
Reuters - 4 linggo ang nakaraan

U.S. Elevance Health, J&J, Primerica

U.S. RESEARCH ROUNDUP-Elevance Health, J&J, Primerica July 18 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Elevance Health, J&J and Primerica, on Thursday. HIGHLIGHTS * Elevance Health Inc ELV.N : Leerink Partners cuts target price to $620 from $630 * J&J JNJ.N : TD Cowen cuts target price to $185 from $195 * Primerica Inc PRI.N : Jefferies raises target price to $249 from $239 * Travelers Companies Inc TRV.N : HS
A
A
O
P
Q
A
A
C
Reuters - 1 buwan ang nakaraan

U.S. Nvidia, Qualcomm, Tesla

U.S. RESEARCH ROUNDUP-Nvidia, Qualcomm, Tesla July 10 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Nvidia, Qualcomm and Tesla, on Wednesday. HIGHLIGHTS * Brighthouse Financial Inc BHF.O : Jefferies raises to buy from hold * Legalzoom.Com Inc LZ.O : JP Morgan cuts to neutral from overweight * Nvidia Corp NVDA.O : KeyBanc raises target price to $180 * Qualcomm Inc QCOM.O : KeyBanc raises target price to $225 * Tesla
A
A
A
A
A
C
G
M
M
N
P
Q
S
T
A
A
A
C
O
B
T
A
A
A
A
C
G
L
U
Reuters - 2 buwan ang nakaraan

Masimo COO Muhsin to resign if activist investor Politan takes control

UPDATE 2-Masimo COO Muhsin to resign if activist investor Politan takes control Adds background throughout July 1 (Reuters) - Masimo MASI.O Chief Operating Officer Bilal Muhsin has told the board he would resign if activist investor Politan Capital Management takes control of the company and CEO Joe Kiani is removed, according to a regulatory filing.
A
S
Reuters - 2 buwan ang nakaraan

U.S. Alimera Sciences, Comtech Telecommunications, Eli Lilly

U.S. RESEARCH ROUNDUP-Alimera Sciences, Comtech Telecommunications, Eli Lilly June 25 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Alimera Sciences, Comtech Telecommunications and Eli Lilly, on Tuesday. HIGHLIGHTS * Alimera Sciences Inc ALIM.O : Craig-Hallum cuts to hold from buy * Comtech Telecommunications Corp CMTL.O : Jefferies raises to hold from underperform * Eli Lilly LLY.N : Truist Securities raises targe
A
A
E
D
U
V
A
B
C
C
C
F
M
Reuters - 2 buwan ang nakaraan

EU to impose duties of up to 38% on Chinese electric vehicles

CORRECTED-INSTANT VIEW-EU to impose duties of up to 38% on Chinese electric vehicles Corrects attribution of comment in paragraph 49 to EUROPEAN UNION CHAMBER OF COMMERCE IN CHINA June 12 (Reuters) - The European Commission said on Wednesday it would set provisional duties of up to 38.1% on imports of Chinese electric vehicles, a move likely to draw possible retaliation from China.
A
B
P
R
T
V
Reuters - 2 buwan ang nakaraan

EU to impose duties of up to 38% on Chinese electric vehicles

INSTANT VIEW-EU to impose duties of up to 38% on Chinese electric vehicles Adds new comments June 12 (Reuters) - The European Commission said on Wednesday it would set provisional duties of up to 38.1% on imports of Chinese electric vehicles, a move likely to draw possible retaliation from China. COMMENTARY: Carmakers OLIVER ZIPSE, CEO, BMW BMWG.DE "This decision for additional import duties is the wrong way to go.
A
B
P
T
V
Reuters - 2 buwan ang nakaraan

EU to impose duties of up to 38% on Chinese electric vehicles

INSTANT VIEW-EU to impose duties of up to 38% on Chinese electric vehicles Adds new comments June 12 (Reuters) - The European Commission said on Wednesday it would set provisional duties of up to 38.1% on imports of Chinese electric vehicles, a move likely to draw possible retaliation from China. COMMENTARY: Carmakers VOLKSWAGEN VOWG_p.DE : "Countervailing duties are generally not suitable for strengthening the competitiveness of the European automotive industry in the long term - we reject them
A
B
P
V
Reuters - 2 buwan ang nakaraan

U.S. Asana, GE Vernova, New Gold

U.S. RESEARCH ROUNDUP-Asana, GE Vernova, New Gold June 3 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Asana, GE Vernova and New Gold, on Monday. HIGHLIGHTS * Asana ASAN.N : HSBC raises to hold from reduce * GE Vernova Inc GEV.N : JP Morgan raises target price to $186 from $176 * New Gold Inc NGD.N : CIBC raises to outperformer from neutral * Owens Corning OC.N : Barclays raises target price to $190 from $160 * Rad
A
A
B
B
I
S
A
A
E
M
M
P
Reuters - 3 buwan ang nakaraan

U.S. Connectone Bancorp, Hormel Foods, UMB Financial

U.S. RESEARCH ROUNDUP-Connectone Bancorp, Hormel Foods, UMB Financial May 31 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Connectone Bancorp, Hormel Foods and UMB Financial, on Friday. HIGHLIGHTS * Connectone Bancorp Inc CNOB.O : KBW cuts to market perform from outperform * Hancock Whitney Corp HWC.O : KBW raises to outperform from market perform * Hormel Foods Corp HRL.N : JP Morgan raises to neutral from underwe
A
A
C
M
M
N
P
S
A
U
A
B
D
E
E
X
M
Reuters - 3 buwan ang nakaraan

S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT

BUZZ - S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT S&P 500 .SPX Top Performers Percent Change HP Inc HPQ.N +17.1% Best Buy Co Inc BBY.N +13.3% Warner Bros Discovery Inc WBD.OQ +6.1% Bath & Body Works Inc BBWI.N +4.2% CVS Health Corp CVS.N +4.2% Bottom Performers Percent Change Salesforce Inc CRM.N -20.8% ServiceNow Inc NOW.N -1
A
S
U
S
Reuters - 3 buwan ang nakaraan

U.S. STOCKS HP, Salesforce, C3.ai

BUZZ-U.S. STOCKS ON THE MOVE-HP, Salesforce, C3.ai Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock indexes fell on Thursday, with a plummeting Salesforce weighing on the Dow, while data showing the economy had grown slower than previously expected in the first quarter supported bets of rate cuts from the Federal Reserve this year.
A
J
P
S
T
A
U
U
D
G
S
W
Reuters - 3 buwan ang nakaraan

S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT

BUZZ - S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT S&P 500 .SPX Top Performers Percent Change HP Inc HPQ.N +17.1% Best Buy Co Inc BBY.N +11.4% ETSY Inc ETSY.OQ +4.1% Insulet Corp PODD.OQ +4.0% Enphase Energy Inc ENPH.OQ +3.8% Bottom Performers Percent Change Salesforce Inc CRM.N -20.4% ServiceNow Inc NOW.N -9.5% Hormel Foods Co
A
S
U
E
S
W
Reuters - 3 buwan ang nakaraan

Agilent hits 6-month low after cutting full-year revenue forecast

BUZZ-Agilent hits 6-month low after cutting full-year revenue forecast Updates ** Shares of medical equipment maker Agilent Technologies A.N fall as much as 1 3.9 % to a six-month low of $125.30 * * Stock set for its biggest one-day pct. drop in five years if losses hold ** Co late Wednesday lowered full-year revenue forecast to between $6.42 bln a
A
Reuters - 3 buwan ang nakaraan

Waters Corp dips over peer Agilent's FY revenue forecast cut

BUZZ-Waters Corp dips over peer Agilent's FY revenue forecast cut ** Shares of lab equipment maker Waters Corp WAT.N fall 5% to $310.84 in early morning trade after peer Agilent Technologies A.N lowers annual revenue forecast ** Agilent's FY forecast cut and narrow Q2 revenue est. miss on Wednesday was due to soft demand from its biotech customers
A
W

Kundisyon

Mga Patok na Assets

Disclaimer: Ang mga kabilang sa XM Group ay nagbibigay lang ng serbisyo sa pagpapatupad at pag-access sa aming Online Trading Facility, kung saan pinapahintulutan nito ang pagtingin at/o paggamit sa nilalaman na makikita sa website o sa pamamagitan nito, at walang layuning palitan o palawigin ito, at hindi din ito papalitan o papalawigin. Ang naturang pag-access at paggamit ay palaging alinsunod sa: (i) Mga Tuntunin at Kundisyon; (ii) Mga Babala sa Risk; at (iii) Kabuuang Disclaimer. Kaya naman ang naturang nilalaman ay ituturing na pangkalahatang impormasyon lamang. Mangyaring isaalang-alang na ang mga nilalaman ng aming Online Trading Facility ay hindi paglikom, o alok, para magsagawa ng anumang transaksyon sa mga pinansyal na market. Ang pag-trade sa alinmang pinansyal na market ay nagtataglay ng mataas na lebel ng risk sa iyong kapital.

Lahat ng materyales na nakalathala sa aming Online Trading Facility ay nakalaan para sa layuning edukasyonal/pang-impormasyon lamang at hindi naglalaman – at hindi dapat ituring bilang naglalaman – ng payo at rekomendasyon na pangpinansyal, tungkol sa buwis sa pag-i-invest, o pang-trade, o tala ng aming presyo sa pag-trade, o alok para sa, o paglikom ng, transaksyon sa alinmang pinansyal na instrument o hindi ginustong pinansyal na promosyon.

Sa anumang nilalaman na galing sa ikatlong partido, pati na ang mga nilalaman na inihanda ng XM, ang mga naturang opinyon, balita, pananaliksik, pag-analisa, presyo, ibang impormasyon o link sa ibang mga site na makikita sa website na ito ay ibibigay tulad ng nandoon, bilang pangkalahatang komentaryo sa market at hindi ito nagtataglay ng payo sa pag-i-invest. Kung ang alinmang nilalaman nito ay itinuring bilang pananaliksik sa pag-i-invest, kailangan mong isaalang-alang at tanggapin na hindi ito inilaan at inihanda alinsunod sa mga legal na pangangailangan na idinisenyo para maisulong ang pagsasarili ng pananaliksik sa pag-i-invest, at dahil dito ituturing ito na komunikasyon sa marketing sa ilalim ng mga kaugnay na batas at regulasyon. Mangyaring siguruhin na nabasa at naintindihan mo ang aming Notipikasyon sa Hindi Independyenteng Pananaliksik sa Pag-i-invest at Babala sa Risk na may kinalaman sa impormasyong nakalagay sa itaas, na maa-access dito.

Babala sa Risk: Maaaring malugi ang iyong kapital. Maaaring hindi nababagay sa lahat ang mga produktong naka-leverage. Mangyaring isaalang-alang ang aming Pahayag sa Risk.